Ticlopidine-induced pancytopenia: Treatment of agranulocytosis with granulocyte colony-stimulating factor;Ticlopidin-induzierte Panzytopenie: Therapie der Agranulozytose mit granulozytenkoloniestimulierendem Faktor

Medizinische Klinik

Volumn 91, Issue 6, 1996, Pages 417-419

  Schneider, Arved Winfried ^a,b   Fechler, Ludwig ^a   Gilfrich, Hans Joachim ^a  

^a St Kathannen Krankhs Frankfurt/M   (Germany)

^b St Katharinen Krankenhaus   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CEFOTAXIME; GRANULOCYTE COLONY STIMULATING FACTOR; OMEPRAZOLE; TICLOPIDINE;

AGED; AGRANULOCYTOSIS; ARTICLE; CASE REPORT; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; HUMAN; HUMAN TISSUE; MALE; PANCYTOPENIA; PNEUMONIA; SUBCUTANEOUS DRUG ADMINISTRATION;

AGED; AGRANULOCYTOSIS; BIOPSY, NEEDLE; BONE MARROW; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INTRACRANIAL EMBOLISM AND THROMBOSIS; MALE; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 0029841632     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Balsano, F., P. Rizzon, F Violi, D. Scrutinio, C. Cimminiello, F Aguglia, C. Pasotti, G. Rudelli and the Studio della Ticlopidina nell'Angina Instabile Group: Anti-platelet treatment with ticlopidine in unstable angina. Circulation 82 (1990), 17-26.
2. Busse, O.: Thrombozytenfunktionshemmer zur Schlaganfallprophylaxe. Ticlopidin als Alternative zu Azetylsalizylsäure. Fottschr. Med. 112 (1994), 365-366.
3. Editorial: Ticlopidine. Lancet 337 (1991), 459-460.
4. Elias, M., N. Reichmann, E. Flatau: Bone marrow aplasia associated with ticlopidine therapy. Amer. J. Hemat. 44 (1993), 289-290.
5. Gent, M , J. A. Blakely, J. D Easton, D. J. Ellis, V. C. Hachinski, J W. Harbison, E. Panak, R. S. Roberts, J. Sicurella, A. G. G. Turopie and the CATS Group: The Canadian-American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet I (1989), 1261-1266.
6. Gerson, S. L., G. Guillion, H. S. Yeh, C. Maser: Granulocyte colony-stimulating factor for clozapine-induced agranulocytosis. Lancet 340 (1992), 1097.
7. Gruner, U., S. tho Pesch, S. Spittler, H. E. Schaefer, U. Peter Therapie einer Clozapin-induzierten Agranulozytose mit granulozytenkoloniestimulierendem Faktor. Dtsch. med. Wschr 119 (1994), 1467-1470
8. Mass, W. K., J. D. Easton, H. P. Adams, W Pryse-Phillips, B A, Molony, S. Anderson, Ph. D. Kamm, B Kamm for the Ticlopidine Aspirin Stroke Study Group: A randomized trial comparing ticlopidine hydrochloride with aspirin for prevention of stroke in high-risk patients. New Engl. J. Med. 321 (1989), 501-507.
9. Khelif, A., D. Assouline, M. French, G. Chaumentin, J.-J. Viala: Ticlopidine and aplastic anaemia. Brit. J Haemat. 83 (1993), 678-681.
10. Kinchenko, A. A., V. I. Prekina, N. P. Repinskaia, I. N. Novichkova, N M. Ter Gevondian, I. V. Vinogradova: The efficacy of riclid in treating intermittent claudication in atherosclerotic stenosis of the arteries of the lower extremities. Ter. Arkh. 66 (1994), 23-26
11. Legarra, G., J. M, Beltran de Hecedia, I. Olabarria, M. V. G. Menoyo, J. J. Villareal: Agranulocitosis inducida por Ticlopidina Sangre (Barc) 39 (1994), 229-230.
12. Lord, B. I., H. Gurney, J. Chang, N. Thatcher, D. Crowther, T. M. Dexter: Haematopoetic cell kinetics in humans treated with rGM-CSF. Int. J. Cancer 50 (1992), 26-31.
13. Martin-Nunez, G., R. R. Fdez-Soria, F. Sanchez-Gil, E. Benitez-Cano: Aplastic anaemia and ticlopidine Brit. J. Haemat. 85 (1993), 633-640.
14. Ono, K , K. Kurohara, M. Yoshihara, Y. Shimamoto, M. Yamaguchi: Agranulocytosis caused by ticlopidine and its mechanism. Amer. J Hemat. 37 (1991), 239-242.
15. Patton, W. N.: Use of colony stimulating factors for the treatment of drug-induced agranulocytosis (correspondence). Brit. J. Haemat. 84 (1993), 184-185.
16. Ruiz-Irastorza, G., J. J. Alonso, J. J. Iglesias, G. Aguirre: Granulocyte colony-stimulating factor for neutropenia to ticlopidine. Acta haemat. (Basel) 91 (1994), 106-107.
17. Saltiel, E., A. Ward. Ticlopidine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states. Drugs 34 (1987), 222-261
18. Simon, B., H. Klemsorge, P Müller: Vergleich der gastroduodenalen Verträglichkeit von Ticlopidm und Acetylsalicylsäure Dtsch. med Wschr 118 (1993), 1146-1149.
19. Steinmetz, H. T., L. Mantovani, V. Diehl: Die klinische Bedeutung von koloniestimulierenden Faktoren. Med. Klin. 88 (1993), 146-154.